title: FDA bridging analyses confirmed in clinical trial.
authors.affiliation: Division of Antiviral Products, US Food and Drug Administration, Washington, DC.
authors.forename: Poonam
authors.initials: P
authors.lastname: Mishra
authors.forename: Jeffry
authors.initials: J
authors.lastname: Florian
authors.forename: Jeffrey
authors.initials: J
authors.lastname: Murray
mesh_terms: D000998:Antiviral Agents / Q000627:therapeutic use*; D017277:Drug Approval / Q000379:methods*; D016903:Drug Monitoring / Q000379:methods*; D019698:Hepatitis C, Chronic / Q000188:drug therapy*; D006801:Humans; D009842:Oligopeptides / Q000627:therapeutic use*; D011392:Proline / Q000031:analogs & derivatives*
chemical_list: D000998:Antiviral Agents; D009842:Oligopeptides; D011392:Proline